Free Trial

Lexeo Therapeutics (LXEO) Institutional Ownership

Lexeo Therapeutics logo
$4.79 +0.07 (+1.48%)
Closing price 08/14/2025 04:00 PM Eastern
Extended Trading
$4.88 +0.09 (+1.86%)
As of 04:24 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Lexeo Therapeutics (NASDAQ:LXEO)

Current
Institutional Ownership
Percentage
60.67%
Number of
Institutional Buyers
(last 12 months)
55
Total
Institutional Inflows
(last 12 months)
$66.73M
Number of
Institutional Sellers
(last 12 months)
17
Total
Institutional Outflows
(last 12 months)
$48.48M
Get LXEO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lexeo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

LXEO Institutional Buying and Selling by Quarter

Lexeo Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/14/2025 Pale Fire Capital SE27,650$111K0.0%+46.3%0.083%
8/14/2025 Cerity Partners LLC12,447$50K0.0%N/A0.037%
8/13/2025 Affinity Asset Advisors LLC3,589,355$14.43M2.0%+142.4%10.812%
8/13/2025 Quadrature Capital Ltd29,779$120K0.0%N/A0.090%
8/8/2025 Intech Investment Management LLC13,682$55K0.0%+20.7%0.041%
8/8/2025 Geode Capital Management LLC578,081$2.33M0.0%-1.4%1.741%
8/6/2025 Savant Capital LLC29,667$119K0.0%N/A0.089%
7/30/2025 Ethic Inc.10,726$44K0.0%N/A0.032%
7/30/2025 Privium Fund Management B.V.178,356$753K0.2%+11.3%0.537%
7/25/2025 CWM LLC10,351$42K0.0%+150.3%0.031%
7/25/2025 Vanguard Personalized Indexing Management LLC15,000$60K0.0%N/A0.045%
7/15/2025 Palumbo Wealth Management LLC56,303$226K0.1%N/A0.170%
6/27/2025Goldman Sachs Group Inc.79,108$275K0.0%-13.0%0.238%
5/29/2025 Rhumbline Advisers30,192$105K0.0%+19.8%0.091%
5/21/2025 Acadian Asset Management LLC24,648$85K0.0%N/A0.074%
5/16/2025Woodline Partners LP837,014$2.90M0.0%-2.5%2.521%
5/16/2025Goldman Sachs Group Inc.79,108$275K0.0%-13.0%0.238%
5/16/2025Millennium Management LLC1,071,489$3.72M0.0%+654.8%3.228%
5/16/2025AQR Capital Management LLC50,337$175K0.0%+370.0%0.152%
5/16/2025Adage Capital Partners GP L.L.C.237,953$826K0.0%-89.2%0.717%
5/15/2025Vestal Point Capital LP1,136,249$3.94M0.3%-5.3%3.423%
5/15/2025DAFNA Capital Management LLC378,083$1.31M0.4%-3.8%1.139%
5/14/2025 Affinity Asset Advisors LLC1,480,881$5.14M0.5%N/A4.461%
5/13/2025 Ground Swell Capital LLC23,123$80K0.2%N/A0.070%
5/12/2025 Nuveen LLC36,050$125K0.0%N/A0.109%
5/9/2025 Charles Schwab Investment Management Inc.56,174$195K0.0%-12.1%0.169%
5/9/2025 Privium Fund Management B.V.160,198$556K0.1%+16.0%0.483%
3/24/2025Wellington Management Group LLP76,981$507K0.0%+48.3%0.233%
2/18/2025Frazier Life Sciences Management L.P.955,515$6.29M0.3%-23.6%2.889%
2/17/2025Woodline Partners LP858,691$5.65M0.0%+0.8%2.597%
2/17/2025Vestal Point Capital LP1,200,000$7.90M0.5%+41.2%3.629%
2/17/2025Point72 Asset Management L.P.750,235$4.94M0.0%+102.5%2.269%
2/17/2025Omega Fund Management LLC1,184,636$7.80M6.5%-49.7%3.582%
2/17/2025Millennium Management LLC141,951$934K0.0%+282.5%0.429%
2/17/2025Janus Henderson Group PLC4,339,254$28.51M0.0%+15.3%13.121%
2/17/2025 Deutsche Bank AG13,226$87K0.0%+172.8%0.040%
2/17/2025DAFNA Capital Management LLC393,083$2.59M0.7%+56.9%1.189%
2/17/2025 Corton Capital Inc.13,771$91K0.1%N/A0.042%
2/17/2025Bridgeway Capital Management LLC65,000$428K0.0%N/A0.197%
2/17/2025Bank of America Corp DE30,376$200K0.0%-21.7%0.092%
He Called Nvidia at $1.10. Now, He Says THIS Stock Will… (Ad)

The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.

See his full breakdown of the seven stocks to own now
2/17/2025BNP Paribas Financial Markets34,527$227K0.0%+523.1%0.104%
2/17/2025Allostery Investments LP5,054$33K0.0%N/A0.015%
2/14/2025Jane Street Group LLC14,512$95K0.0%-59.3%0.044%
2/14/2025 Northern Trust Corp214,284$1.41M0.0%+7.1%0.648%
2/14/2025Boothbay Fund Management LLC147,807$973K0.0%+37.5%0.447%
2/14/2025D1 Capital Partners L.P.2,203,900$14.50M0.2%-12.1%6.664%
2/14/2025Adage Capital Partners GP L.L.C.2,209,615$14.54M0.0%-14.9%6.682%
2/14/2025Price T Rowe Associates Inc. MD10,425$69K0.0%N/A0.032%
2/14/2025 Altium Capital Management LLC405,000$2.67M0.8%N/A1.225%
2/13/2025 Marshall Wace LLP17,794$117K0.0%N/A0.054%
2/13/2025 Jump Financial LLC20,400$134K0.0%N/A0.062%
2/13/2025 Walleye Capital LLC61,930$407K0.0%N/A0.187%
2/13/2025 Barclays PLC55,161$363K0.0%+9.9%0.167%
2/13/2025ADAR1 Capital Management LLC169,505$1.12M0.2%+196.5%0.513%
2/13/2025 Aristides Capital LLC29,285$193K0.0%N/A0.089%
2/13/2025Wells Fargo & Company MN11,156$73K0.0%+49.9%0.034%
2/12/2025 Geode Capital Management LLC567,383$3.74M0.0%+2.6%1.716%
2/12/2025Wellington Management Group LLP76,981$507K0.0%+48.3%0.233%
2/12/2025 JPMorgan Chase & Co.13,371$88K0.0%+30.1%0.040%
2/11/2025 Privium Fund Management B.V.138,115$909K0.2%N/A0.418%
2/4/2025 Bank of New York Mellon Corp50,660$333K0.0%+5.6%0.153%
1/30/2025 Rhumbline Advisers25,197$166K0.0%+19.6%0.076%
1/24/2025China Universal Asset Management Co. Ltd.7,011$46K0.0%N/A0.021%
1/17/2025 SG Americas Securities LLC10,960$72K0.0%N/A0.033%
12/26/2024 JPMorgan Chase & Co.10,278$93K0.0%+135.6%0.031%
12/13/2024Exome Asset Management LLC88,148$797K0.5%N/A0.267%
11/19/2024 Barclays PLC50,210$454K0.0%+162.2%0.152%
11/16/2024 Geode Capital Management LLC553,247$5.00M0.0%+86.5%1.673%
11/15/2024Frazier Life Sciences Management L.P.1,250,786$11.31M0.5%N/A3.783%
11/15/2024 Barclays PLC50,210$454K0.0%+162.2%0.152%
11/15/2024Jane Street Group LLC35,677$323K0.0%+33.3%0.108%
11/15/2024Wellington Management Group LLP51,892$469K0.0%+134.8%0.157%
11/15/2024State Street Corp253,946$2.30M0.0%+29.4%0.768%
11/15/2024RA Capital Management L.P.546,554$4.94M0.1%-18.8%1.653%
11/15/2024Point72 Asset Management L.P.370,407$3.35M0.0%N/A1.120%
11/15/2024Polar Asset Management Partners Inc.59,800$541K0.0%-8.4%0.181%
11/15/2024Ikarian Capital LLC257,216$2.33M0.3%N/A0.778%
11/15/2024Jacobs Levy Equity Management Inc.30,346$274K0.0%N/A0.092%
11/15/2024Janus Henderson Group PLC3,763,195$34.00M0.0%+18.9%11.383%
11/14/2024PDT Partners LLC26,608$241K0.0%N/A0.080%
11/14/2024Braidwell LP728,777$6.59M0.2%-47.3%2.204%
11/14/2024Eventide Asset Management LLC1,855,986$16.78M0.3%-44.9%5.614%
11/14/2024Verition Fund Management LLC777,320$7.03M0.0%+84.5%2.351%
11/14/2024Vestal Point Capital LP850,000$7.68M0.6%+1.2%2.571%
11/14/2024 MetLife Investment Management LLC14,223$129K0.0%+121.5%0.043%
11/13/2024BNP Paribas Financial Markets5,541$50K0.0%+184.2%0.017%
11/12/2024 Charles Schwab Investment Management Inc.63,874$577K0.0%+107.0%0.193%
10/24/2024Novo Holdings A S1,122,581$10.15M0.5%-22.6%3.407%
10/23/2024 Values First Advisors Inc.7,446$67K0.0%N/A0.023%
8/20/2024Novo Holdings A S1,450,500$23.27M1.2%-11.5%4.403%
One stock to replace Nvidia (Ad)

Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.

Click to get the full details on Eric Fry's "Nvidia alternative" right here.
8/1/2024 Rhumbline Advisers13,357$214K0.0%+37.3%0.041%
7/26/2024 Bank of New York Mellon Corp31,806$510K0.0%+12.3%0.097%
5/17/2024RA Capital Management L.P.660,938$10.36M0.1%N/A2.006%
5/17/2024 Artal Group S.A.801,716$12.57M0.3%+32.9%2.434%
5/16/2024Janus Henderson Group PLC2,540,785$39.80M0.0%+9.0%7.713%
5/14/2024 American International Group Inc.5,053$79K0.0%N/A0.015%
5/10/2024 Vanguard Group Inc.481,755$7.55M0.0%+15.8%1.462%
5/1/2024BNP Paribas Financial Markets4,781$75K0.0%N/A0.015%
4/29/2024Cornell University126,258$1.98M30.0%N/A0.383%
2/20/2024Eventide Asset Management LLC3,002,831$40.30M0.7%N/A11.268%
(Data available from 1/1/2016 forward)

LXEO Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of LXEO shares?

During the previous two years, 70 institutional investors and hedge funds held shares of Lexeo Therapeutics. The most heavily invested institutionals were Janus Henderson Group PLC ($28.51M), Eventide Asset Management LLC ($16.78M), D1 Capital Partners L.P. ($14.50M), Affinity Asset Advisors LLC ($14.43M), Artal Group S.A. ($12.57M), Novo Holdings A S ($10.15M), and Blackstone Inc. ($9.34M).Learn more on Lexeo Therapeutics' institutional investors.

What percentage of Lexeo Therapeutics' stock is owned by institutional investors?

60.67% of Lexeo Therapeutics' stock is owned by institutional investors. Learn more on LXEO's institutional investor holdings.

Which institutional investors have been buying Lexeo Therapeutics' stock?

Of the 63 institutional investors that purchased Lexeo Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Affinity Asset Advisors LLC ($3.59M), Eventide Asset Management LLC ($3.00M), Omega Fund Management LLC ($2.16M), Janus Henderson Group PLC ($1.39M), Frazier Life Sciences Management L.P. ($1.25M), Millennium Management LLC ($1.03M), and Point72 Asset Management L.P. ($750.24K).

How much institutional buying is happening at Lexeo Therapeutics?

Institutional investors have bought a total of 10,952,135 shares in the last 24 months. This purchase volume represents approximately $66.73M in transactions.

Which of Lexeo Therapeutics' major shareholders have been selling company stock?

Of the 17 institutional investors that sold Lexeo Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Adage Capital Partners GP L.L.C. ($2.36M), Eventide Asset Management LLC ($1.51M), Omega Fund Management LLC ($1.17M), Braidwell LP ($653.70K), Novo Holdings A S ($515.72K), D1 Capital Partners L.P. ($302.71K), and Frazier Life Sciences Management L.P. ($295.27K).

How much institutional selling is happening at Lexeo Therapeutics?

Institutional investors have sold a total of 7,112,992 shares in the last 24 months. This volume of shares sold represents approximately $48.48M in transactions.



This page (NASDAQ:LXEO) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners